Feb. 28, 2014
/PRNewswire/ -- Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that
, president and chief executive officer, will present at the Cowen and Company 34
Annual Healthcare Conference on
Wednesday, March 5, 2014
10:00 A.M. ET
The presentation will be webcast live and will be available for access on the Investor Relations section of the corporate website at
. For those who are not available to listen to the live broadcast, the webcast will be archived for 90 days.
About Alimera Sciences, Inc.
Alimera Sciences, Inc., headquartered in
, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera's European operations are conducted from
by its wholly-owned subsidiary, Alimera Sciences Limited.
ICR, LLCfor Alimera Sciences
SOURCE Alimera Sciences, Inc.